Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

NCT06191263 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: RVU120
DRUG: Venetoclax

Sponsor

Ryvu Therapeutics SA